November 3, 2015
Janssen Applys to EMA to Expand Use of Imbruvica
Janssen-Cilag International NV announced on Tuesday the submission of a Type II variation application to the European Medicines Agency (EMA) seeking…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Jane Griffiths
September 26, 2015
Janssen’s daratumumab accepted for treatment of European patients with heavily pre-treated multiple myeloma
Janssen-Cilag International NV has announced on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European…